Consolidated Condensed Statements of Shareholders' Equity (Unaudited) - USD ($)	Total	Preferred Stock Series A	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Total Shareholders’ Equity (Deficit) Attributable to 60P	Noncontrolling Interest on Shareholders
Balance at Dec. 31, 2023	$ 4,798,096	$ 9,858,040	$ 10	$ 27,457,373	$ (32,580,850)	$ 135,561	$ 4,870,134	$ (72,038)
Balance (in Shares) at Dec. 31, 2023		78,803	96,847
Issuance of common stock and warrants, net of underwriting discounts and offering costs paid at closing and deferred offering costs (Note 6)	1,898,296		$ 9	1,898,287			1,898,296
Issuance of common stock and warrants, net of underwriting discounts and offering costs paid at closing and deferred offering costs (Note 6) (in Shares)			87,683
Issuance of common stock upon exercise of Pre-Funded Warrants	4,995		$ 1	4,994			4,995
Issuance of common stock upon exercise of Pre-Funded Warrants (in shares)			8,326
Issuance of shares for RSUs (in Shares)			3,201
Net foreign translation gain (loss)	(3,894)					(3,894)	(3,894)
Net income (loss)	427,985				430,470		430,470	(2,485)
Balance at Mar. 31, 2024	7,125,478	$ 9,858,040	$ 20	29,360,654	(32,150,380)	131,667	7,200,001	(74,523)
Balance (in Shares) at Mar. 31, 2024		78,803	196,057
Balance at Dec. 31, 2023	4,798,096	$ 9,858,040	$ 10	27,457,373	(32,580,850)	135,561	4,870,134	(72,038)
Balance (in Shares) at Dec. 31, 2023		78,803	96,847
Share-based compensation expense	15,246
Net income (loss)	(5,906,739)
Balance at Sep. 30, 2024	5,962,847	$ 9,567,439	$ 38	34,815,790	(38,482,920)	139,207	6,039,554	(76,707)
Balance (in Shares) at Sep. 30, 2024		76,480	372,397
Balance at Mar. 31, 2024	7,125,478	$ 9,858,040	$ 20	29,360,654	(32,150,380)	131,667	7,200,001	(74,523)
Balance (in Shares) at Mar. 31, 2024		78,803	196,057
Issuance of common stock upon exercise of Pre-Funded Warrants	4,995		$ 1	4,994			4,995
Issuance of common stock upon exercise of Pre-Funded Warrants (in shares)			8,326
Issuance of shares for RSUs (in Shares)			1,069
Voluntary return of shares issued to vendor for services (in shares)			(2,000)
Net foreign translation gain (loss)	3,137					3,137	3,137
Net income (loss)	(4,174,226)				(4,172,755)		(4,172,755)	(1,471)
Balance at Jun. 30, 2024	2,959,384	$ 9,858,040	$ 21	29,365,648	(36,323,135)	134,804	3,035,378	(75,994)
Balance (in Shares) at Jun. 30, 2024		78,803	203,452
Voluntary conversion of Series A Preferred Stock into common stock		$ (290,601)	$ 1	290,600
Voluntary conversion of Series A Preferred Stock into common stock (in Shares)		(2,323)	14,667
Issuance of common stock pursuant to ATM Offering, net of offering costs paid at closing and deferred offering costs (Note 6)	1,729,810		$ 14	1,729,796			1,729,810
Issuance of common stock pursuant to ATM Offering, net of offering costs paid at closing and deferred offering costs (Note 6) (in Shares)			135,568
Issuance of warrants in Private Placement, net of offering costs paid at closing and deferred offering costs	3,414,502			3,414,502			3,414,502
Share-based compensation expense	15,246			15,246			15,246
Net foreign translation gain (loss)	4,403					4,403	4,403
Net income (loss)	(2,160,498)				(2,159,785)		(2,159,785)	(713)
Issuance of common stock for fractional shares pursuant to Reverse Stock Split rounding adjustment			$ 2	(2)
Issuance of common stock for fractional shares pursuant to Reverse Stock Split rounding adjustment (in shares)			18,710
Balance at Sep. 30, 2024	5,962,847	$ 9,567,439	$ 38	34,815,790	(38,482,920)	139,207	6,039,554	(76,707)
Balance (in Shares) at Sep. 30, 2024		76,480	372,397
Balance at Dec. 31, 2024	3,955,006	$ 9,567,439	$ 57	34,860,590	(40,527,957)	135,471	4,035,600	(80,594)
Balance (in Shares) at Dec. 31, 2024		76,480	566,908
Issuance of common stock and warrants pursuant to January 2025 Offering, net of offering costs paid at closing and deferred offering costs (Note 6)	804,346		$ 20	804,326			804,346
Issuance of common stock and warrants pursuant to January 2025 Offering, net of offering costs paid at closing and deferred offering costs (Note 6) (in Shares)			204,312
Issuance of common stock and warrants pursuant to February 2025 Offering, net of offering costs paid at closing and deferred offering costs (Note 6)	908,627		$ 30	908,597			908,627
Issuance of common stock and warrants pursuant to February 2025 Offering, net of offering costs paid at closing and deferred offering costs (Note 6) (in Shares)			300,700
Issuance of common stock upon exercise of Pre-Funded Warrants	1,926		$ 38	1,888			1,926
Issuance of common stock upon exercise of Pre-Funded Warrants (in shares)			385,200
Issuance of shares for annual performance bonuses, net of shares withheld for taxes	103,544		$ 2	103,542			103,544
Issuance of shares for annual performance bonuses, net of shares withheld for taxes (in Shares)			15,809
Share-based compensation expense	142,645			142,645			142,645
Net foreign translation gain (loss)	(9,904)					(9,904)	(9,904)
Net income (loss)	(1,877,301)				(1,876,549)		(1,876,549)	(752)
Issuance of common stock for fractional shares pursuant to Reverse Stock Split rounding adjustment (in shares)			38
Balance at Mar. 31, 2025	4,028,889	$ 9,567,439	$ 147	36,821,588	(42,404,506)	125,567	4,110,235	(81,346)
Balance (in Shares) at Mar. 31, 2025		76,480	1,472,891
Balance at Dec. 31, 2024	3,955,006	$ 9,567,439	$ 57	34,860,590	(40,527,957)	135,471	4,035,600	(80,594)
Balance (in Shares) at Dec. 31, 2024		76,480	566,908
Share-based compensation expense	212,030
Net income (loss)	(5,929,267)
Balance at Sep. 30, 2025	4,346,958	$ 9,567,439	$ 410	41,172,888	(46,454,556)	144,039	4,430,220	(83,262)
Balance (in Shares) at Sep. 30, 2025		76,480	4,104,469
Balance at Mar. 31, 2025	4,028,889	$ 9,567,439	$ 147	36,821,588	(42,404,506)	125,567	4,110,235	(81,346)
Balance (in Shares) at Mar. 31, 2025		76,480	1,472,891
Share-based compensation expense	34,503			34,503			34,503
Net foreign translation gain (loss)	17,242					17,242	17,242
Net income (loss)	(1,734,930)				(1,733,726)		(1,733,726)	(1,204)
Balance at Jun. 30, 2025	2,345,704	$ 9,567,439	$ 147	36,856,091	(44,138,232)	142,809	2,428,254	(82,550)
Balance (in Shares) at Jun. 30, 2025		76,480	1,472,891
Issuance of common stock and warrants pursuant to July 2025 Offering, net of offering costs paid at closing and deferred offering costs (Note 6)	4,281,300		$ 175	4,281,125			4,281,300
Issuance of common stock and warrants pursuant to July 2025 Offering, net of offering costs paid at closing and deferred offering costs (Note 6) (in Shares)			1,753,314
Issuance of common stock upon exercise of Pre-Funded Warrants	878		$ 88	790			878
Issuance of common stock upon exercise of Pre-Funded Warrants (in shares)			878,264
Share-based compensation expense	34,882			34,882			34,882
Net foreign translation gain (loss)	1,230					1,230	1,230
Net income (loss)	(2,317,036)				(2,316,324)		(2,316,324)	(712)
Balance at Sep. 30, 2025	$ 4,346,958	$ 9,567,439	$ 410	$ 41,172,888	$ (46,454,556)	$ 144,039	$ 4,430,220	$ (83,262)
Balance (in Shares) at Sep. 30, 2025		76,480	4,104,469